Source: International Congress 2019 – Pleural infection and complicated pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Klester (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), Y. Shoikhet (Barnaul, Russian Federation), A. Zharikov (Barnaul, Russian Federation). Pulmonary complications in intravenous drug users with and without human immunodeficiency virus co-infection.. 3846

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in human immunodeficiency virus infection Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals Source: Annual Congress 2006 - MP6 – Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals Year: 2006 Totally implantable central venous access device in the treatment of patients with multi- and extensively drug-resistant tuberculosis co-infected with human immunodeficiency virus and with history of illicit drug use. Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Pulmonary manifestations of human herpesvirus-8 during HIV infection Source: Eur Respir J 2013; 42: 1105-1118 Year: 2013 CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection Source: Eur Respir J 2001; 18: Suppl. 33, 479s Year: 2001 Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients Source: Eur Respir J 2002; 20: 28S-39S Year: 2002 Lung disease associated with the human immunodeficiency virus in Brazilian children Source: Eur Respir J 2004; 24: Suppl. 48, 717s Year: 2004 Pulmonary complications of HIV infection Source: Annual Congress 2007 - ACCP 2 - Pulmonary complications of HIV infection Year: 2007 Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome Source: Eur Respir J 2001; 17: 636-640 Year: 2001 Efficacy of intravenous immunoglobulin therapy on the incidence of pneumonia in Iranian patients with common variable immunodeficiency Source: Eur Respir J 2004; 24: Suppl. 48, 357s Year: 2004 Prophylaxis with azithromycin in primary immunodeficiency and bronchiectasis Source: Annual Congress 2005 - New insights in respiratory infections in children Year: 2005 The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen Source: Eur Respir J 2003; 21: 785-788 Year: 2003 Mycobacterium tuberculosis bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 Prevalence of hepatitis c virus infection among patients with COPD Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Impact of adverse drug reactions on treatment interruption in TB patients with and without HIV coinfection Source: ISSN=ISSN 1810-6838, ISBN=, page=190 Year: 2006 Comparative analysis of pneumonia in patients with drug dependence with HIV infection and without HIV. Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Tuberculosis in human immunodeficiency virus (HIV) seropositive and seronegative populations, in a tuberculosis unit of a hospital in Lisbon Source: Eur Respir J 2001; 18: Suppl. 33, 479s Year: 2001 Serosurvey of human immunodeficiency virus infection in children with respiratory disorders from 1990 through 2005 Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Pulmonary involvement in immunodeficiency Source: Eur Respir Monogr 2019; 86: 374-390 Year: 2019 Respiratory infections in HIV patients Source: Annual Congress 2008 - PG18 - Respiratory infections in immunosuppressed children Year: 2008